Skip to Main Content

Paper Details

Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.
Int J Cancer
80
2019
ALK, BRAF, DNA, EGFR, ERBB2, HER2, KEAP1, MET, NSCLC, RET, RNA, ROS1, STK11, TP53, Tyrosine, Tyrosine kinase, advanced NSCLC, exons, formalin, nonsmall cell lung cancer, patient, patients
Author NameAffiliation
Anna-Lena VolckmarInstitute of Pathology, University Hospital Heidelberg
Martina KirchnerInstitute of Pathology, University Hospital Heidelberg
Olaf NeumannInstitute of Pathology, University Hospital Heidelberg
Jan BudcziesInstitute of Pathology, University Hospital Heidelberg
Jan Budczies
Ivo BuchhalterInstitute of Pathology, University Hospital Heidelberg
Ivo BuchhalterGerman Cancer Research Center (DKFZ)
Ivo BuchhalterInstitute of Pathology, University Hospital Heidelberg
Ivo BuchhalterGerman Cancer Research Center (DKFZ)
Michael Allg??uerInstitute of Pathology, University Hospital Heidelberg
Esther HerpelInstitute of Pathology, University Hospital Heidelberg
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg
Peter SchirmacherInstitute of Pathology, University Hospital Heidelberg
Peter Schirmacher
Volker EndrisInstitute of Pathology, University Hospital Heidelberg
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg
Albrecht Stenzinger
  • 1 - 17

Datasets